Prothena Corporation PLC PRTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/30/21 EDT
50.10UNCH (UNCH)
Volume
13,065
Close
50.10quote price arrow up+0.38 (+0.76%)
Volume
159,628
52 week range
9.67 - 67.08

...

Loading . . .
  • Open49.13
  • Day High51.57
  • Day Low48.27
  • Prev Close49.72
  • 52 Week High67.08
  • 52 Week High Date07/09/21
  • 52 Week Low9.67
  • 52 Week Low Date09/29/20

Key Stats

  • Market Cap2.213B
  • Shares Out44.18M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change317.15

KEY STATS

  • Open49.13
  • Day High51.57
  • Day Low48.27
  • Prev Close49.72
  • 52 Week High67.08
  • 52 Week High Date07/09/21
  • 52 Week Low9.67
  • 52 Week Low Date09/29/20
  • Market Cap2.213B
  • Shares Out44.18M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.46
  • YTD % Change317.15

RATIOS/PROFITABILITY

  • EPS (TTM)-3.11
  • P/E (TTM)-16.13
  • Fwd P/E (NTM)91.93
  • EBITDA (MRQ)-118.561M
  • ROE (MRQ)-50.78%
  • Revenue (MRQ)870,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-14,255.73%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Prothena Corporation PLC

There is no recent news for this security.

Profile

MORE
Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002)...
Lars Ekman M.D., Ph.D.
Non-Executive Chairman
Gene Kinney Ph.D.
President
Tran Nguyen
Chief Financial Officer
Karin Walker CPA
Chief Accounting Officer
Address
Dublin 1, 25-28 North Wall Quay
Dublin
A96 T927
Ireland

Top Peers

SYMBOLLASTCHG%CHG
ALXO
ALX Oncology Holdings Inc
58.56-0.89-1.50%
ZNTL
Zentalis Pharmaceuticals Inc
53.21-1.41-2.58%
AXSM
Axsome Therapeutics Inc
48.59-1.98-3.92%
RUBY
Rubius Therapeutics Inc
21.49-1.31-5.75%
CRTX
Cortexyme Inc
56.51+0.48+0.86%